← Eichor
Condition: Telitacicept Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Telitacicept

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Phase 2 · 9 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06375005Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
NA · 1 location(s) · RenJi Hospital · NCT06394063Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Phase 2 · 23 location(s) · Beijing Hospital · NCT05998759Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
Phase 4 · 1 location(s) · Chinese SLE Treatment And Research Group · NCT05962840Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
Phase N/A · 1 location(s) · Tongji Hospital · NCT06458972Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Phase 4 · 1 location(s) · Tongji Hospital · NCT07077486A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Phase 3 · 1 location(s) · RemeGen Co., Ltd. · NCT07249632The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Phase 4 · 1 location(s) · Peking University Third Hospital · NCT06546540A Study of Telitacicept in Lupus Nephritis
Phase 2 · 45 location(s) · RemeGen Co., Ltd. · NCT05680480Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Phase 4 · 1 location(s) · Chinese SLE Treatment And Research Group · NCT05965284The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patien
Phase 2 · 1 location(s) · Nanjing University School of Medicine · NCT07340463Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06979271Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07491016A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powde
Phase 1 · 3 location(s) · RemeGen Co., Ltd. · NCT06549959Efficacy and Safety of Telitacicept in IgAN
NA · 1 location(s) · Ruijin Hospital · NCT06654596Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
Phase 3 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06125405A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Phase 3 · 111 location(s) · Vor Biopharma · NCT06456580
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.